DoD Neurofibromatosis New Investigator Award
The summary for the DoD Neurofibromatosis New Investigator Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Neurofibromatosis New Investigator Award: The intent of the NFRP New Investigator Award is to support the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research. Prior experience in NF research is not required. However, Principal Investigators (PIs) with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field.
Research projects may focus on any phase of research, excluding clinical trials. Applications must include preliminary and/or published data that is relevant to NF and the proposed research project.
Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. For projects involving animal studies, applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at http://www.nc3rs.org.uk/page.asp?id=1357.
Research projects may focus on any phase of research, excluding clinical trials. Applications must include preliminary and/or published data that is relevant to NF and the proposed research project.
Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. For projects involving animal studies, applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at http://www.nc3rs.org.uk/page.asp?id=1357.
Federal Grant Title: | DoD Neurofibromatosis New Investigator Award |
Federal Agency Name: | Dept of the Army USAMRAA |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-15-NFRP-NIA |
Type of Funding: | Cooperative Agreement, Grant |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Military Medical Research and Development |
Current Application Deadline: | Jul 27, 2015 |
Original Application Deadline: | Jul 27, 2015 |
Posted Date: | May 6, 2015 |
Creation Date: | May 6, 2015 |
Archive Date: | Aug 26, 2015 |
Total Program Funding: | $2,880,000 |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
CDMRP Help Desk
Dept. of the Army -- USAMRAA 301-619-7144 - Similar Government Grants
- • DoD Peer Reviewed Medical, Impact Award
- • DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
- • DoD Peer Reviewed Medical, Discovery Award
- • DoD Peer Reviewed Medical, Technology/Therapeutic Development Award
- • DoD Peer Reviewed Medical, Clinical Trial Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • Spinal Cord Injury Research Program Clinical Translation Research Award
- • Spinal Cord Injury Research Program Clinical Trial Award
- • DoD Hearing Restoration Focused Research Award
- • DOD Spinal Cord Injury Research Program Translational Research Award
- • DoD Autism, Clinical Trial Award